Merck Kgaa CFO on Earnings, Consumer Business Options

The transcript discusses the third quarter earnings of a German pharmaceutical company, highlighting its adjusted EBITDA and the challenges faced in the performance materials sector, particularly in liquid crystals. The CFO, Marcus Kuhnert, addresses competition, currency impacts, and strategic decisions, including the potential offloading of the consumer health business. Despite market challenges, the company aims to maintain its guidance and focus on innovative medicines and healthcare pipeline investments.

What strategic options is the company exploring for its Consumer Health business?

Evaluate responses using AI:

OFF

What is the significance of the liquid crystals market for the company?

Evaluate responses using AI:

OFF

What are the company's plans for revitalizing top-line growth in the Performance Materials division?

Evaluate responses using AI:

OFF